Safety and efficacy of insulin detemir combined with OAD [oral anti-diabetic drug] versus insulin NPH [neutral protamine Hagedorn] [insulin-suspension-isophane] combined with OAD in type 2 mellitus.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2009 Actual end date (Jan 2004 ) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual patient number (477) added as reported by ClinicalTrials.gov.